Novartis to buy Excellergy for up to $2 billion
Swiss pharma company Novartis said it will acquire California-based biotech company Excellergy in a deal worth up to $2 billion. Under the agreement, Novartis said it would pay up to…
Swiss pharma company Novartis said it will acquire California-based biotech company Excellergy in a deal worth up to $2 billion. Under the agreement, Novartis said it would pay up to…
The European Union agreed to an overhaul of its customs system, including a crackdown on mainly Chinese e-commerce platforms that face potential fines if they sell illegal or unsafe products…
Oil prices rose on Friday but were set for their first weekly decline since February 9 as US President Donald Trump extended a pause in attacks on Iran's energy plants,…